Royalty Pharma agreed to acquire its external manager, RP Management, in a $1.1 billion deal that it believes will pay for itself in the long-term as it aims to simplify its corporate structure.

Portfolio Receipts expected to be approximately $2,800 million, at the upper end of guidance rangeExciting development-stage pipeline with ...

Royalty Pharma said on Friday it would pay about $1.1 billion to acquire RP Management, an organization that manages the healthcare firm's operations, as it seeks to simplify its corporate structure.

Spencer Pratt may have lost his home in the ongoing Los Angeles wildfires, but he still has some of his Taylor Swift ...

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans. Trump ...

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief ...

Bilfinger (BFLBF) is well-positioned to benefit from strong secular trends. Read more to see why I rate the stock a buy.

Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

Spencer Pratt’s sister, Stephanie Pratt, revealed that Heidi Montag and Spencer Pratt have lost their Los Angeles home in the ...

Donald Trump is stacking his second administration with a slate of Silicon Valley insiders. The president-elect has tapped at ...